Keratosis Clinical Trials

• Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00116649 - Active, not recruiting
  Keratosis
  
• Study of Imiquimod 5% Cream as an Adjunct to Cryotherapy in the Management of Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00110682 - Active, not recruiting
  Keratosis; Actinic Keratosis
  
• Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
  ClinicalTrials.gov Identifier: NCT00294320 - Active, not recruiting
  Actinic Keratosis
  
• Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00027976 - Active, not recruiting
  actinic keratosis
  
• Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
  ClinicalTrials.gov Identifier: NCT00115154 - Completed
  Keratosis
  
• Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00021294 - Active, not recruiting
  actinic keratosis; squamous cell carcinoma of the skin; prevention of skin cancer; basal cell carcinoma of the skin
  
• T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
  ClinicalTrials.gov Identifier: NCT00002811 - Active, not recruiting
  actinic keratosis; prevention of skin cancer
  
• Green Tea Extract in Treating Patients With Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00005097 - Active, not recruiting
  actinic keratosis; squamous cell carcinoma of the skin; prevention of skin cancer; basal cell carcinoma of the skin
  
• Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00103246 - Recruiting
  actinic keratosis; Cutaneous T-Cell Lymphoma; Skin Cancer
  
• 1-Year Follow up to the 1473-IMIQ Study
  ClinicalTrials.gov Identifier: NCT00114023 - Completed
  Keratosis
  
• Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00107965 - Completed
  Keratosis
  
• Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
  ClinicalTrials.gov Identifier: NCT00335179 - Completed
  Actinic Keratosis
  
• A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand
  ClinicalTrials.gov Identifier: NCT00544297 - Active, not recruiting
  Actinic Keratosis
  
• Photodynamic Therapy in Treating Patients With Skin Cancer
  ClinicalTrials.gov Identifier: NCT00002975 - Recruiting
  basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis
  
• Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
  ClinicalTrials.gov Identifier: NCT00304239 - Completed
  Actinic Keratosis
  
• Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
  ClinicalTrials.gov Identifier: NCT00306800 - Completed
  Actinic Keratosis
  
• T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00089180 - Recruiting
  recurrent skin cancer; basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis
  
• Acitretin in Treating Patients With Skin Disease or Skin Cancer
  ClinicalTrials.gov Identifier: NCT00020956 - Active, not recruiting
  actinic keratosis; stage III mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; skin metastases; ...
  
• Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00524485 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Comparision of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head
  ClinicalTrials.gov Identifier: NCT00204542 - Recruiting
  Photosensitivity Disorders
  
• Effect of IDEA-070 on Pain and Inflammation Induced by PDT
  ClinicalTrials.gov Identifier: NCT00269074 - Completed
  Actinic Keratosis
  
• The Effect of Efudex Treatment On Photoaged Skin
  ClinicalTrials.gov Identifier: NCT00121511 - Completed
  Photoaging of skin; Keratosis
  
• Optical Biopsy of Human Skin in Conjunction With Laser Treatment
  ClinicalTrials.gov Identifier: NCT00540566 - Enrolling by invitation
  Malignant Melanoma,; Merkel Cell Carcinoma,; Basal Cell Carcinoma,; Squamous Cell Carcinoma; Atypical Nevi,; Congenital Nevi; Seborrheic Keratosis,; Paget's Disease; Dermatofibroma,; Kaposi's Sarcoma; Hypervascular Congenital Malformations; Port Wine Stain; Hemangioma; Tattoos; Scleroderma; Burns; Normal Skin
  
• The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
  ClinicalTrials.gov Identifier: NCT00005660 - Completed
  Basal Cell Carcinoma; Keratosis Palmaris et Plantaris; Psoriasis
  
• Study of Scaling Disorders and Other Inherited Skin Diseases
  ClinicalTrials.gov Identifier: NCT00001292 - Completed
  Genetic Skin Disease; Keratosis Follicularis; Lamellar Ichthyosis
  
• Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
  ClinicalTrials.gov Identifier: NCT00239135 - Completed
  Keratosis
  
• Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
  ClinicalTrials.gov Identifier: NCT00308854 - Completed
  Actinic Keratosis
  
• PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
  ClinicalTrials.gov Identifier: NCT00308867 - Completed
  Actinic Keratosis
  
• Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00375739 - Completed
  Actinic Keratosis
  
• A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00189267 - Completed
  Actinic Keratosis
  
• PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-Melanoma Skin Cancer
  ClinicalTrials.gov Identifier: NCT00472459 - Completed
  Actinic Keratosis; Warts; Basal Cell Carcinoma; Bowens Disease; Squamous Cell Carcinoma
  
• Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-Grunwald-Giemsa Stained Tissue Smear
  ClinicalTrials.gov Identifier: NCT00218868 - Completed
  Carcinoma, Basal Cell; Porokeratosis, Disseminated Superficial Actinic